DUBLIN–(BUSINESS WIRE)–The “Biomanufacturing Viral Detection and Quantification Market – A Global and Regional Analysis: Focus on Offering Type, Technology, Application, End User, and Region – Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering.
The global biomanufacturing viral detection and quantification market, valued at $0.474 billion in 2022, is projected to witness substantial growth, reaching $1.15 billion by 2032 at a CAGR of 9.37% during the forecast period 2023-2032.
The market is expected to be driven by the increasing utilization of biopharmaceutical products and technological advancements in the viral testing industry.
Market Segmentation
-
Offering Type: Consumables, Instruments, Services
- The consumables segment dominated the market in 2022, fueled by the growing adoption of kits, assays, and accessories for viral testing during biomanufacturing processes.
-
Technology: PCR, ELISA, Flow Cytometry, Plaque Assay, Others
- PCR, a widely-used molecular biology technique, held the major share in 2022 due to its effectiveness in identifying and measuring viral nucleic acids during biopharmaceutical production.
-
Application: Blood and Blood Products Manufacturing, Vaccines and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and Tissue Products Manufacturing
- The blood and blood products manufacturing segment led the market in 2022, as viral testing is crucial in verifying the safety and quality of these biomanufactured products.
-
End User: Life Science Companies, Testing Laboratories, CROs and CDMOs
- The life science companies segment accounted for the largest share in 2022, emphasizing the importance of viral detection and quantification in medication development, production, and evaluation.
-
Region: North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
- North America held the largest share (38.72%) in 2022, owing to the presence of key players and increased funding. Asia-Pacific is expected to grow at the highest CAGR of 10.47% during 2023-2032, driven by continuous R&D and a supportive regulatory landscape.
Market Dynamics
- Demand Drivers: Rising utilization of biopharmaceuticals and technological advancements in viral detection and quantification.
- Market Restraints: High cost of advanced viral detection equipment and lack of trained professionals in viral detection and quantification.
- Market Opportunities: Increasing need for viral contamination considerations in the development of cell and gene therapies.
Key Market Players and Competition Synopsis
- Danaher Corporation
- Merck KGaA
- New England Biolabs
- TAKARA HOLDINGS INC.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Sartorius AG
- Charles River Laboratories
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- Promega Corporation
- QIAGEN N.V.
- Genscript Biotech Corporation
- Norgen Biotek Corp.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 273 |
| Forecast Period | 2023 – 2032 |
| Estimated Market Value (USD) in 2023 | $0.51 Billion |
| Forecasted Market Value (USD) by 2032 | $1.15 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/q9rwi7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900